Peer review reports
From: Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report
| Original Submission |
| 25 Apr 2016 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
| Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
| Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
| Publishing |
| 16 Jun 2016 |
Editorially accepted |
|
| 7 Jul 2016 |
Article published |
10.1186/s12885-016-2463-2
|
Learn about peer review
